Keros Therapeutics to receive $20 million Takeda milestone payment for elritercept Phase 3 dosingPUBT·18 hours agoKROS-2.84%TAK-1.07%
Mamegano Reiterates Buy on Takeda as Q1 Beat and Pipeline Progress Support Unchanged Price ObjectiveTip Ranks·1 day ago, 07:45 AMTAK-1.07%4502
Takeda Pharmaceutical Company: Revenue up 10.2% on FX tailwinds; core profit flat at CER; FY2026 outlook cautiousQuartr·1 day ago, 02:03 AMTAK-1.07%4502
Takeda Pharmaceutical Company: Q1 FY2026 delivered robust core revenue growth, driven by new launches and disciplined investmentQuartr·1 day ago, 01:51 AMTAK-1.07%4502
Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track | TAK Stock NewsStockTitan·1 day ago, 05:37 PMTAK-1.07%4502
Takeda Pharmaceutical Company Limited Stock 12‑Month Price Target Raised to $19.2, Implies 10% UpsideTradingView·Jul 28 at 09:20 AMTAK-1.07%4502
Takeda says China approves ORZEYFUL orexin agonist for narcolepsy type 1PUBT·Jul 22 at 09:10 PMTAK-1.07%4502
‘Historic breakthrough’: China approves novel drug ahead of US, Japan and EuropeSCMP·Jul 21 at 11:04 PMTAK-1.07%4502
Weekly Recap: India approves QDENGA and LATITUDE PsO trial successTradingView·Jul 20 at 05:14 PMTAK-1.07%4502
Novartis and Takeda drugs gain rare blood cancer routine use on NHSPharmaceutical Technology·Jul 20 at 05:46 AM4502TAK-1.07%
